METROPOLITAN LIFE INSURANCE CO/NY - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 155 filers reported holding ASSERTIO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$75,465
-8.9%
21,874
+33.9%
0.00%
-50.0%
Q1 2019$82,844
+14.1%
16,340
-18.8%
0.00%
+100.0%
Q4 2018$72,608
-38.6%
20,1130.0%0.00%
-50.0%
Q3 2018$118,26420,1130.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Rubric Capital Management LP 3,600,316$4,500,0000.51%
Aristides Capital LLC 140,625$176,0000.14%
TSP Capital Management Group, LLC 248,100$310,0000.13%
Anson Funds Management LP 86,767$108,0000.12%
Factorial Partners, LLC 97,000$122,360,0000.06%
GSA CAPITAL PARTNERS LLP 267,309$334,0000.04%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,113,351$1,392,000,0000.04%
DELTEC ASSET MANAGEMENT LLC 145,700$182,0000.04%
OAKTREE CAPITAL MANAGEMENT LP 1,492,455$1,865,0000.04%
OXFORD ASSET MANAGEMENT LLP 930,134$1,163,0000.03%
View complete list of ASSERTIO THERAPEUTICS INC shareholders